Research Bridge Partners and Lyda Hill Philanthropies Support Life Science Spinouts at UT Southwestern Medical Center
AUSTIN, Texas, April 24, 2023 — Research Bridge Partners – which makes formative investments in biomedical startup companies based on the breakthroughs of […]
MorphImmune, Inc., a Research Bridge Partners Portfolio Company, Appoints Ronald Martell as President and CEO
— The former President and CEO of Nuvelution Pharma also served as the CEO of three public biopharmaceutical companies, including Sevion and […]
Research Bridge Partners’ Portfolio Company, Novosteo, Inc., Closes $5.5 Million in Series A Financing
– The Purdue University Spinout’s NOV004, the first-ever targeted bone anabolic agent, has shown promise in accelerating fracture healing – AUSTIN, Texas, […]
Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio Advances Dr. Lola Eniola-Adefeso’s Immune Cell Targeted Therapeutic Platform
— University of Michigan BioInterfaces Institute spinout has developed a technology to treat a wide range of life-threatening inflammatory diseases, including Acute […]
Research Bridge Partners Makes Seed Capital Investment In Erisyon, Inc.
— University of Texas spinout is developing world’s first single-molecule protein sequencing platform — AUSTIN, TX (November 30, 2020) – Research Bridge […]
Research Bridge Partners Makes Seed Investment in Eradivir, Inc.
AUSTIN, Texas, April 15, 2020 /PRNewswire/ -- Research Bridge Partners—a not-for-profit that enhances the societal and economic returns on America's investment in research universities by bridging mid-continent university innovators and commercialization resources nationally—announced the investment of seed capital in Eradivir, Inc.
Research Bridge Partners Makes Seed Capital Investment In Novosteo, Inc.
Research Bridge Partners—a not-for-profit that enhances the societal and economic returns on America's investment in research universities by bridging mid-continent university innovators and commercialization resources nationally—announced the investment of seed capital in Novosteo, Inc.
Research Bridge Partners Launches Seed Fund To Catalyze Commercialization Of Mid-Continent Research
AUSTIN, Texas, July 16, 2019 -- Research Bridge Partners—a not-for-profit that enhances the societal and economic returns on America's investment in research universities by bridging mid-continent university innovators and commercialization resources nationally—has launched a program-related investment (PRI) seed fund to invest in promising university spinouts.